Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Long-term results of brachytherapy in early mobile tongue cancer with 10-year minimal follow-up.

Abdalmear MM, Tomita M, Shibuya H.

Anticancer Res. 2013 Jan;33(1):317-24.

PMID:
23267163
2.

Treatment outcome with low-dose-rate interstitial brachytherapy in early-stage oral tongue cancers.

Bhalavat RI, Mahantshetty UM, Tole S, Jamema SV.

J Cancer Res Ther. 2009 Jul-Sep;5(3):192-7. doi: 10.4103/0973-1482.57125.

3.

Interstitial brachytherapy for stage I and II squamous cell carcinoma of the oral tongue: factors influencing local control and soft tissue complications.

Fujita M, Hirokawa Y, Kashiwado K, Akagi Y, Kashimoto K, Kiriu H, Matsuura K, Ito K.

Int J Radiat Oncol Biol Phys. 1999 Jul 1;44(4):767-75.

PMID:
10386633
4.

An analysis of mandibular bone complications in radiotherapy for T1 and T2 carcinoma of the oral tongue.

Fujita M, Hirokawa Y, Kashiwado K, Akagi Y, Kashimoto K, Kiriu H, Ohtani K, Wada T.

Int J Radiat Oncol Biol Phys. 1996 Jan 15;34(2):333-9.

PMID:
8567334
5.

Results of low- and high-dose-rate interstitial brachytherapy for T3 mobile tongue cancer.

Kakimoto N, Inoue T, Inoue T, Murakami S, Furukawa S, Yoshida K, Yoshioka Y, Yamazaki H, Tanaka E, Shimizutani K.

Radiother Oncol. 2003 Aug;68(2):123-8.

PMID:
12972306
6.

Long-term outcomes with high-dose-rate brachytherapy for the management of base of tongue cancer.

Takácsi-Nagy Z, Oberna F, Koltai P, Hitre E, Major T, Fodor J, Polgár C.

Brachytherapy. 2013 Nov-Dec;12(6):535-41. doi: 10.1016/j.brachy.2013.07.001. Epub 2013 Aug 27.

PMID:
23988507
7.

Phase III trial of high- vs. low-dose-rate interstitial radiotherapy for early mobile tongue cancer.

Inoue T, Inoue T, Yoshida K, Yoshioka Y, Shimamoto S, Tanaka E, Yamazaki H, Shimizutani K, Teshima T, Furukawa S.

Int J Radiat Oncol Biol Phys. 2001 Sep 1;51(1):171-5.

PMID:
11516867
8.

Interstitial high-dose-rate brachytherapy in the treatment of base of tongue carcinoma.

Takácsi-Nagy Z, Polgár C, Oberna F, Somogyi A, Major T, Remenár E, Fodor J, Kásler M, Németh G.

Strahlenther Onkol. 2004 Dec;180(12):768-75.

PMID:
15592696
9.

Long-term outcomes after external beam irradiation and brachytherapy boost for base-of-tongue cancers.

Gibbs IC, Le QT, Shah RD, Terris DJ, Fee WE, Goffinet DR.

Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2):489-94.

PMID:
12957261
10.

High-dose rate interstitial brachytherapy for stage I-II tongue cancer.

Umeda M, Komatsubara H, Nishimatsu N, Yokoo S, Shibuya Y, Komori T.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000 Nov;90(5):667-70.

PMID:
11077395
11.

Radiotherapy of early tongue cancer in patients less than 40 years old.

Yoshida K, Koizumi M, Inoue T, Yamazaki H, Imai A, Shiomi H, Yoshioka Y, Tanaka E, Shimizutani K, Furukawa S, Inoue T.

Int J Radiat Oncol Biol Phys. 1999 Sep 1;45(2):367-71.

PMID:
10487557
12.

Interstitial brachytherapy and neck dissection for Stage III squamous cell carcinoma of the mobile tongue.

Ihara N, Shibuya H, Yoshimura R, Oota S, Miura M, Watanabe H.

Acta Oncol. 2005;44(7):709-16.

PMID:
16227161
13.

Excellent functional outcome in patients with squamous cell carcinoma of the base of tongue treated with external irradiation and interstitial iodine 125 boost.

Horwitz EM, Frazier AJ, Martinez AA, Keidan RD, Clarke DH, Lacerna MD, Gustafson GS, Heil E, Dmuchowski CF, Vicini FA.

Cancer. 1996 Sep 1;78(5):948-57.

14.

Influence of age on the results of brachytherapy for early tongue cancer.

Yamazaki H, Inoue T, Yoshida K, Imai A, Yoshioka Y, Tanaka E, Shimamoto S, Nakamura S, Inoue T, Nakamura H, Furukawa S, Shimizutani K.

Int J Radiat Oncol Biol Phys. 2001 Mar 15;49(4):931-6.

PMID:
11240233
15.

The importance of interstitial radiotherapy in the treatment of the base of tongue tumors: a retrospective analysis.

Takácsi-Nagy Z, Oberna F, Polgár C, Somogyi A, Major T, Németh G.

Neoplasma. 2001;48(1):76-81.

PMID:
11327543
16.

Phase III trial of high and low dose rate interstitial radiotherapy for early oral tongue cancer.

Inoue T, Inoue T, Teshima T, Murayama S, Shimizutani K, Fuchihata H, Furukawa S.

Int J Radiat Oncol Biol Phys. 1996 Dec 1;36(5):1201-4.

PMID:
8985043
17.

High dose rate brachytherapy for early stage oral tongue cancer.

Leung TW, Wong VY, Kwan KH, Ng TY, Wong CM, Tung SY, Leung LC, O SK.

Head Neck. 2002 Mar;24(3):274-81.

PMID:
11891960
18.

Therapeutic results for 100 patients with cancer of the mobile tongue treated with low dose rate interstitial irradiation.

Kobayashi Y, Karasawa K, Komiya Y, Hanyu N, Okamoto M, Chang TC, Kiguchi Y, Uchida I, Yoshida S, Asoda S.

Anticancer Res. 2007 May-Jun;27(3B):1689-92.

19.

Factors affecting mandibular complications in low dose rate brachytherapy for oral tongue carcinoma with special reference to spacer.

Miura M, Takeda M, Sasaki T, Inoue T, Nakayama T, Fukuda H, Hoshi A, Hoshina M, Shibuya H.

Int J Radiat Oncol Biol Phys. 1998 Jul 1;41(4):763-70.

PMID:
9652836
20.

Supplemental Content

Support Center